LRRK2 and Parkinson disease: In addition, these data suggest that quantifying LLOMe-mediated alterations in pT73-Rab10, rather than pT73-Rab10 levels per se, may be a suitable approach to nominate PD patients with lysosomal dysfunction and consequent LRRK2 activation.